With 7 FDA-approved drugs and another 7 compounds in preclinical development or clinical trials, Southern Research's track record in early drug discovery continues to grow. In addition, Southern Research has evaluated approximately 50 percent of all FDA- approved cancer drugs currently available for patients.
You may also download a printable version (2.3 MB) of this chart in Acrobat PDF format.